|
1
|
Michotte A, Neyns B, Chaskis C, Sadones J
and In’t Veld P: Neuropathological and molecular aspects of
low-grade and high-grade gliomas. Acta Neurol Belg. 104:148–153.
2004.PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Surawicz TS, Davis F, Freels S, Laws ER Jr
and Menck HR: Brain tumor survival: results from the National
Cancer Data Base. J Neurooncol. 40:151–160. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeAngelis LM: Brain tumors. N Engl J Med.
344:114–123. 2001. View Article : Google Scholar
|
|
5
|
Nakamizo A, Marini F, Amano T, et al:
Human bone marrow-derived mesenchymal stem cells in the treatment
of gliomas. Cancer Res. 65:3307–3318. 2005.PubMed/NCBI
|
|
6
|
Aboody KS, Brown A, Rainov NG, et al:
Neural stem cells display extensive tropism for pathology in adult
brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA.
97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Benedetti S, Pirola B, Pollo B, et al:
Gene therapy of experimental brain tumors using neural progenitor
cells. Nat Med. 6:447–450. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ehtesham M, Kabos P, Gutierrez MA, et al:
Induction of glioblastoma apoptosis using neural stem cell-mediated
delivery of tumor necrosis factor-related apoptosis-inducing
ligand. Cancer Res. 62:7170–7174. 2002.PubMed/NCBI
|
|
9
|
Ehtesham M, Kabos P, Kabosova A, Neuman T,
Black KL and Yu JS: The use of interleukin 12-secreting neural stem
cells for the treatment of intracranial glioma. Cancer Res.
62:5657–5663. 2002.PubMed/NCBI
|
|
10
|
Kim SK, Cargioli TG, Machluf M, et al:
PEX-producing human neural stem cells inhibit tumor growth in a
mouse glioma model. Clin Cancer Res. 11:5965–5970. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SK, Kim SU, Park IH, et al: Human
neural stem cells target experimental intracranial medulloblastoma
and deliver a therapeutic gene leading to tumor regression. Clin
Cancer Res. 12:5550–5556. 2006. View Article : Google Scholar
|
|
12
|
Lee DH, Ahn Y, Kim SU, et al: Targeting
rat brainstem glioma using human neural stem cells and human
mesenchymal stem cells. Clin Cancer Res. 15:4925–4934. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sasportas LS, Kasmieh R, Wakimoto H, et
al: Assessment of therapeutic efficacy and fate of engineered human
mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA.
106:4822–4827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Amano S, Li S, Gu C, et al: Use of
genetically engineered bone marrow-derived mesenchymal stem cells
for glioma gene therapy. Int J Oncol. 35:1265–1270. 2009.PubMed/NCBI
|
|
15
|
Li S, Gao Y, Tokuyama T, et al:
Genetically engineered neural stem cells migrate and suppress
glioma cell growth at distant intracranial sites. Cancer Lett.
251:220–227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Tokuyama T, Yamamoto J, Koide M,
Yokota N and Namba H: Potent bystander effect in suicide gene
therapy using neural stem cells transduced with herpes simplex
virus thymidine kinase gene. Oncology. 69:503–508. 2005. View Article : Google Scholar
|
|
17
|
Li S, Tokuyama T, Yamamoto J, Koide M,
Yokota N and Namba H: Bystander effect-mediated gene therapy of
gliomas using genetically engineered neural stem cells. Cancer Gene
Ther. 12:600–607. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Namba H, Tagawa M, Iwadate Y, Kimura M,
Sueyoshi K and Sakiyama S: Bystander effect-mediated therapy of
experimental brain tumor by genetically engineered tumor cells. Hum
Gene Ther. 9:5–11. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schichor C, Birnbaum T, Etminan N, et al:
Vascular endothelial growth factor A contributes to glioma-induced
migration of human marrow stromal cells (hMSC). Exp Neurol.
199:301–310. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ehtesham M, Yuan X, Kabos P, et al: Glioma
tropic neural stem cells consist of astrocytic precursors and their
migratory capacity is mediated by CXCR4. Neoplasia. 6:287–293.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Serfozo P, Schlarman MS, Pierret C, Maria
BL and Kirk MD: Selective migration of neuralized embryonic stem
cells to stem cell factor and media conditioned by glioma cell
lines. Cancer Cell Int. 6:12006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hata N, Shinojima N, Gumin J, et al:
Platelet-derived growth factor BB mediates the tropism of human
mesenchymal stem cells for malignant gliomas. Neurosurgery.
66:144–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okita K, Ichisaka T and Yamanaka S:
Generation of germline-competent induced pluripotent stem cells.
Nature. 448:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takahashi K, Okita K, Nakagawa M and
Yamanaka S: Induction of pluripotent stem cells from fibroblast
cultures. Nat Protoc. 2:3081–3089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mohanam S, Sawaya R, McCutcheon I,
Ali-Osman F, Boyd D and Rao JS: Modulation of in vitro invasion of
human glioblastoma cells by urokinase-type plasminogen activator
receptor antibody. Cancer Res. 53:4143–4147. 1993.PubMed/NCBI
|
|
26
|
Amabile G and Meissner A: Induced
pluripotent stem cells: current progress and potential for
regenerative medicine. Trends Mol Med. 15:59–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koch P, Kokaia Z, Lindvall O and Brustle
O: Emerging concepts in neural stem cell research: autologous
repair and cell-based disease modelling. Lancet Neurol. 8:819–829.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ronaghi M, Erceg S, Moreno-Manzano V and
Stojkovic M: Challenges of stem cell therapy for spinal cord
injury: human embryonic stem cells, endogenous neural stem cells,
or induced pluripotent stem cells? Stem Cells. 28:93–99.
2010.PubMed/NCBI
|
|
29
|
Yu J and Thomson JA: Pluripotent stem cell
lines. Genes Dev. 22:1987–1997. 2008. View Article : Google Scholar
|
|
30
|
Cheng P, Gao ZQ, Liu YH and Xue YX:
Platelet-derived growth factor BB promotes the migration of bone
marrow-derived mesenchymal stem cells towards C6 glioma and
up-regulates the expression of intracellular adhesion molecule-1.
Neurosci Lett. 451:52–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Heese O, Disko A, Zirkel D, Westphal M and
Lamszus K: Neural stem cell migration toward gliomas in vitro.
Neuro Oncol. 7:476–484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brat DJ, Bellail AC and van Meir EG: The
role of interleukin-8 and its receptors in gliomagenesis and
tumoral angiogenesis. Neuro Oncol. 7:122–133. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mentlein R and Held-Feindt J:
Pleiotrophin, an angiogenic and mitogenic growth factor, is
expressed in human gliomas. J Neurochem. 83:747–753. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Teicher BA: Malignant cells, directors of
the malignant process: role of transforming growth factor-beta.
Cancer Metastasis Rev. 20:133–143. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nagashima G, Suzuki R, Asai J and Fujimoto
T: Immunohistochemical analysis of reactive astrocytes around
glioblastoma: an immunohistochemical study of postmortem
glioblastoma cases. Clin Neurol Neurosurg. 104:125–131. 2002.
View Article : Google Scholar
|
|
36
|
Dunn IF, Heese O and Black PM: Growth
factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J
Neurooncol. 50:121–137. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hamel W and Westphal M: Growth factors in
gliomas revisited. Acta Neurochir. 142:113–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Das AV, James J, Zhao X, Rahnenfuhrer J
and Ahmad I: Identification of c-Kit receptor as a regulator of
adult neural stem cells in the mammalian eye: interactions with
Notch signaling. Dev Biol. 273:87–105. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tran PB, Ren D, Veldhouse TJ and Miller
RJ: Chemokine receptors are expressed widely by embryonic and adult
neural progenitor cells. J Neurosci Res. 76:20–34. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Baudino TA, McKay C, Pendeville-Samain H,
et al: c-Myc is essential for vasculogenesis and angiogenesis
during development and tumor progression. Genes Dev. 16:2530–2543.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Miura K, Okada Y, Aoi T, et al: Variation
in the safety of induced pluripotent stem cell lines. Nat
Biotechnol. 27:743–745. 2009. View
Article : Google Scholar : PubMed/NCBI
|
